Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Introduction: Deficits in somatostatin-positive gamma-aminobutyric acid interneurons (SST+ GABA cells) are commonly reported in human studies of mood and anxiety disorder patients. A causal link between SST+ cell dysfunction and symptom-related behaviors has been proposed based on rodent studies showing that chronic stress, a major risk factor for mood and anxiety disorders, induces a low SST+ GABA cellular phenotype across corticolimbic brain regions; that lowering Sst, SST+ cell, or GABA functions induces depressive-/anxiety-like behaviors (a rodent behavioral construct collectively defined as “behavioral emotionality”); and that disinhibiting SST+ cells has antidepressant-like effects. Recent studies found that compounds preferentially potentiating receptors mediating SST+ cell functions, α5-GABAA receptor positive allosteric modulators (α5-PAMs), achieved antidepressant-like effects. Together, the evidence suggests that SST+ cells regulate mood and cognitive functions that are disrupted in mood disorders and that rescuing SST+ cell function via α5-PAM may represent a targeted therapeutic strategy. Methods: We developed a mouse model allowing chemogenetic manipulation of brain-wide SST+ cells and employed behavioral characterization 30 minutes after repeated acute silencing to identify contributions to symptom-related behaviors. We then assessed whether an α5-PAM, GL-II-73, could rescue behavioral deficits. Results: Brain-wide SST+ cell silencing induced features of stress-related illnesses, including elevated neuronal activity and plasma corticosterone levels, increased anxiety- and anhedonia-like behaviors, and impaired short-term memory. GL-II-73 led to antidepressant- and anxiolytic-like improvements among behavioral deficits induced by brain-wide SST+ cell silencing. Conclusion: Our data validate SST+ cells as regulators of mood and cognitive functions and demonstrate that bypassing low SST+ cell function via α5-PAM represents a targeted therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 1×
“Further, an exogenous formulation of the neurosteroid allopregnanolone was recently approved for postpartum depression and is believed to act partially as a PAM at extrasynaptic GABAA-R compartments where α5-GABAA-Rs are preferentially located (Farrant and Nusser, 2005; Lüscher and Möhler, 2019).”
BackgroundChan, K. Y., Jang, M. J., Yoo, B. B., Greenbaum, A., Ravi, N., Wu, W.-L., Sánchez-Guardado, L., Lois, C., Mazmanian, S. K., Deverman, B. E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4593 · Cited by 1,578
Depression Is the Leading Cause of Disability Around the World
Friedrich, M. J. (2017) · JAMA · doi:10.1001/jama.2017.3826 · Cited by 1,459
The use of c-fos as a metabolic marker in neuronal pathway tracing
Dragunow, M., & Faull, R. (1989) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(89)90150-7 · Cited by 1,416 · cited 1×
“Forty-eight hours after the last test, SsthSyn-hM4Di-mCherry mice from behavioral experiments were injected with Veh or CNO and perfused 110 minutes later, approximating CNO + c-Fos peaks, to quantify neuronal activation following SST+ cell silencing (indexed by c-Fos+ cell counts) (Dragunow and Faull, 1989; Ferguson…”
MethodA toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing
Madisen, L., Mao, T., Koch, H., Zhuo, J.-M., Berenyi, A., Fujisawa, S., Hsu, Y.-W. A., Garcia, A. J., Gu, X., Zanella, S., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3078 · Cited by 1,398
Global Burden of Disease and the Impact of Mental and Addictive Disorders
Rehm, J., & Shield, K. D. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0997-0 · Cited by 1,388
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061 · cited 1×
“, 2013) but previously relied on high-dose systemic administration (Deverman et al., 2016; Chan et al., 2017).”
BackgroundThe GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846 · cited 15×
“In adults, IHC quantification revealed high viral transduction efficiency (mPFC = 95 ± 2%, dHPC = 96 ± 2%, Amy = 56 ± 9%, overall = 82 ± 5”
BackgroundInfluentialInvited review c-Fos as a transcription factor: a stressful (re)view from a functional map
Kovács, K. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00023-0 · Cited by 740 · cited 2×
“Based on established roles for GABA and SST in inhibitory regulation of local neuronal activity and endocrine signaling (Yavorska and Wehr, 2016), chemogenetic SST+ cell silencing was next validated in a separate cohort of SsthSyn-hM4Di-mCherry mice by quantifying neuronal activity via c-Fos+ cell counts (Kovács, 1998…”
MethodGaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Distinct Subtypes of Somatostatin-Containing Neocortical Interneurons Revealed in Transgenic Mice
Ma, Y., Hu, H., Berrebi, A. S., Mathers, P. H., & Agmon, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0661-06.2006 · Cited by 432
Ferguson, S. M., Eskenazi, D., Ishikawa, M., Wanat, M. J., Phillips, P. E. M., Dong, Y., Roth, B. L., & Neumaier, J. F. (2011) · Nature Neuroscience · doi:10.1038/nn.2703 · Cited by 418
Guilloux, J.-P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., Tseng, G. C., Lewis, D. A., & Sibille, E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.113 · Cited by 378 · cited 1×
“Among these, GABA neurons coexpressing the neuropeptide somatostatin (SST+ GABA cells, or SST+ cells) appear to be selectively vulnerable, wherein deficits were identified downstream of causal factors such as chronic stress and reduced neurotrophic factor signaling (Guilloux et al., 2012; Tripp et al., 2012).”
BackgroundSelf-citationFee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Self-citationJendryka, M., Palchaudhuri, M., Ursu, D., van der Veen, B., Liss, B., Kätzel, D., Nissen, W., & Pekcec, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41088-2 · Cited by 296
Tripp, A., Oh, H., Guilloux, J.-P., Martinowich, K., Lewis, D. A., & Sibille, E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020248 · Cited by 273 · cited 1×
“Among these, GABA neurons coexpressing the neuropeptide somatostatin (SST+ GABA cells, or SST+ cells) appear to be selectively vulnerable, wherein deficits were identified downstream of causal factors such as chronic stress and reduced neurotrophic factor signaling (Guilloux et al., 2012; Tripp et al., 2012).”
BackgroundSelf-citationEvidence of Cortical Inhibitory Deficits in Major Depressive Disorder
Levinson, A. J., Fitzgerald, P. B., Favalli, G., Blumberger, D. M., Daigle, M., & Daskalakis, Z. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.025 · Cited by 261
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
Sibille, E., Morris, H. M., Kota, R. S., & Lewis, D. A. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001616 · Cited by 217
Self-citationFuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
Reliability of the chronic mild stress model of depression: A user survey
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.001 · Cited by 198 · cited 4×
“However, the well-noted replicability challenges of individual behavioral tests (Willner, 2017) justified development of the PhenoTyper Test (a fully automated test with higher reproducibility than EPM and OFT; Prevot et al., 2019b) and Z-scoring methods that increase the power and reliability of…”
MethodInfluentialReduced somatostatin in subgenual anterior cingulate cortex in major depression
Tripp, A., Kota, R. S., Lewis, D. A., & Sibille, E. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.014 · Cited by 190
Self-citationSomatostatin-Expressing Inhibitory Interneurons in Cortical Circuits
Yavorska, I., & Wehr, M. (2016) · Frontiers in Neural Circuits · doi:10.3389/fncir.2016.00076 · Cited by 185
Abbas, A. I., Sundiang, M. J. M., Henoch, B., Morton, M. P., Bolkan, S. S., Park, A. J., Harris, A. Z., Kellendonk, C., & Gordon, J. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.029 · Cited by 183
Soumier, A., & Sibille, E. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.76 · Cited by 136 · cited 7×
“Whereas past approaches used region-specific cell knockdown or Sst deletion (Soumier and Sibille, 2014; Lin and Sibille, 2015), we employed brain-wide inhibitory DREADDs that inhibit presynaptic firing and neurotransmitter release (Zhu and Roth, 2014), thus aiming to silence both GABA and SST functions.”
BackgroundMethodResultInfluentialSelf-citationAli, A. B., & Thomson, A. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm160 · Cited by 129
Gomez, A. F., Barthel, A. L., & Hofmann, S. G. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1472767 · Cited by 125
Fischell, J., Van Dyke, A. M., Kvarta, M. D., LeGates, T. A., & Thompson, S. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.112 · Cited by 122
Hu, H., Cavendish, J. Z., & Agmon, A. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00195 · Cited by 120 · cited 1×
“This may be due to lower IHC detectability in SstCre mice that have reduced Sst levels and contain small numbers of non-SST Cre- or GFP-expressing cells (Ma et al., 2006; Taniguchi et al., 2011; Hu et al., 2013; Viollet et al., 2017).”
Ren, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.009 · Cited by 114
Zanos, P., Nelson, M. E., Highland, J. N., Krimmel, S. R., Georgiou, P., Gould, T. D., & Thompson, S. M. (2017) · eNeuro · doi:10.1523/eneuro.0285-16.2017 · Cited by 106
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
The Role of Genetic Sex in Affect Regulation and Expression of GABA-Related Genes Across Species
Seney, M. L., Chang, L.-C., Oh, H., Wang, X., Tseng, G. C., Lewis, D. A., & Sibille, E. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00104 · Cited by 78
Self-citationGholizadeh, S., Tharmalingam, S., MacAldaz, M. E., & Hampson, D. R. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.076 · Cited by 61 · cited 1×
“eB capsids have enhanced GABAergic interneuron transduction (Gholizadeh et al., 2013) but previously relied on high-dose systemic administration (Deverman et al.”
Method
Cited by
Larsen, B., Cui, Z., Adebimpe, A., Pines, A., Alexander-Bloch, A., Bertolero, M., Calkins, M. E., Gur, R. E., Gur, R. C., Mahadevan, A. S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8750 · Cited by 80
“Previous cross-species research has linked E:I disruptions to the manifestation of mood symptomatology, with alterations in both GABA and glutamate neurotransmitter systems being implicated (24, 57).”
BackgroundReduced inhibition in depression impairs stimulus processing in human cortical microcircuits
Yao, H. K., Guet-McCreight, A., Mazza, F., Moradi Chameh, H., Prevot, T. D., Griffiths, J. D., Tripathy, S. J., Valiante, T. A., Sibille, E., & Hay, E. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110232 · Cited by 55
Self-citationRuiz-De-La-Cruz, G., Welsh, T. H., Randel, R. D., & Sifuentes-Rincón, A. M. (2024) · Genes · doi:10.3390/genes15080981 · Cited by 4
“In mammals, the population of interneurons -aminobutyric acid The decreased function of cells expressing SST together with GABA induces depression or anxiety-like behaviors [26].”
Background
Metadata
- Authors
- Fee, C., Prevot, T. D., Misquitta, K., Knutson, D. E., Li, G., Mondal, P., Cook, J. M., Banasr, M., & Sibille, E.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-01-13
- Volume
- 24
- Issue
- 6
- Pages
- 505-518
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W3120731683
- Cited by
- 45
- References
- 34
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.